StockNews.com began coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Aptevo Therapeutics Stock Performance Shares of APVO opened at $0.14 on Thursday. The firm’s fifty day simple moving average is $0.16 and its 200-day simple […]